U.S. Food and Drug Administration Approves Ibrance | New Drug for Advanced Breast Cancer

May 5, 2015:

On February 3, 2015, the Food and Drug Administration approved a new drug called Ibrance for postmenopausal women with advanced breast cancer.

More:

Leave a Reply

Your email address will not be published. Required fields are marked *